Management of gynecologic surgery in the patient with factor XI deficiency: A review of the literature

Obstetrical and Gynecological Survey

Volumn 67, Issue 5, 2012, Pages 291-297

  Steward, Ryan G ^a   Saleh, Oussama A ^a   James, Andra H ^b   Shah, Anish A ^a   Price, Thomas M ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 11 CONCENTRATE; BLOOD CLOTTING FACTOR CONCENTRATE; DESMOPRESSIN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; ANTICOAGULANT THERAPY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; ERYTHROCYTE TRANSFUSION; GYNECOLOGIC SURGERY; HUMAN; LAPAROTOMY; OOCYTE RETRIEVAL; OVARIECTOMY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE HEMORRHAGE; PROTEIN BLOOD LEVEL; REVIEW; RISK BENEFIT ANALYSIS; UTERINE CERVIX CONIZATION; VAGINAL HYSTERECTOMY;

ANTIFIBRINOLYTIC AGENTS; BLOOD LOSS, SURGICAL; DEAMINO ARGININE VASOPRESSIN; FACTOR VIIA; FACTOR XI; FACTOR XI DEFICIENCY; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HEMOSTASIS; HEMOSTATICS; HUMANS; PLASMA; POSTOPERATIVE HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RECOMBINANT PROTEINS;

EID: 84861621334     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3182524da0     Document Type: Review

References (59)

1. Rosenthal R, Dreskin O, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med. 1953;82:171-174.
2. Bolton-Maggs P. Factor XI deficiency and its management. Haemophilia. 2000;6:100-109. (Pubitemid 30468300)
3. Shpilberg O, Peretz H, Zivelin A, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood. 1995;86:3267-3268.
4. Zivelin A, Bauduer F, Ducout L, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood. 2002;99: 2448-2454. (Pubitemid 34525431)
5. Saunders R, Shiltagh N, Gomez K, et al. Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency. Thromb Haemost. 2009;102:183-420.
6. Gomez K, Bolton-Maggs P. Factor XI deficiency. Haemophilia. 2008;14:1183-1189.
7. Bolton-Maggs P. Factor XI deficiency-resolving the enigma? Hematology Am Soc Hematol Educ Program. 2009;97-105.
8. Emsley J, McEwan P, Gailani D. Structure and function of factor XI. Blood. 2010;115:2569-2577.
9. Meijers J, Davie E, Chung D. Expression of human blood coagulation factor XI: characterization of the defect in factor XI type III deficiency. Blood. 1992;79:1435-1440.
10. Franchini M, Veneri D, Lippi G. Inherited factor XI deficiency: a concise review. Hematology. 2006;11:307-309. (Pubitemid 46957651)
11. Bolton-Maggs PH. Bleeding problems in factor XI deficient women. Haemophilia. 1999;5:155-159. (Pubitemid 29326764)
12. Kadir R, Economides D, Lee C. Factor XI deficiency in women. Am J Hematol. 1999;60:48-54. (Pubitemid 28565851)
13. Bouma B, Meijers J. Fibrinolysis and the contact system: a role for factor XI in the down-regulation of fibrinolysis. Thromb Haemost. 1999;82:243-250.
14. Von dem Borne P, Bajzar L, Meijers J, Nesheim M, Bouma B. Thrombin-mediated activation of factor XI results in a thrombinactivatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis. J Clin Invest. 1997;99:2323-2327. (Pubitemid 27227707)
15. Keeling D, Tait C, Makris M. Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia. 2008;14:671-684. (Pubitemid 352016021)
16. Hancock J, Wieland K, Pugh R, et al. A molecular genetic study of factor XI deficiency. Blood. 1991;77:1942-1948.
17. Bolton-Maggs P, Patterson D, Wensley R, Tuddenham E. Definition of the bleeding tendency in factor XI-deficient kindreds-a clinical and laboratory study. Thromb Haemost. 1995;73:194-202.
18. Bolton-Maggs PH. The management of factor XI deficiency. Haemophilia. 1998;4:683-688. (Pubitemid 28351905)
19. Ragni M, Sinha D, Seaman F, Lewis J, Spero J, Walsh P. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood. 1985;65:719-724. (Pubitemid 15131483)
20. Woodruff R, Sullenger B, Becker R. The many faces of the contact pathway and their role in thrombosis. J Thromb Thrombolysis. 2011;32:9-20.
21. Maureane H. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003;17(suppl 1):S1-S5.
22. Hoffman M, Monroe DI. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-965. (Pubitemid 32573743)
23. Hoffman M. Remodeling the blood coagulation cascade. J Thromb Thrombolysis. 2003;16:17-20. (Pubitemid 38477219)
24. Kravtsov DV, Matafonov A, Tucker EI, et al. Factor XI contributes to thrombin generation in the absence of factor XII. Blood. 2009;114:452-458.
25. Asakai R, Chung D, Davie E, Seligsohn E. Factor XI deficiency in Ashkenazi Jews in Israel. N Engl J Med. 1991;325:153-158.
26. Salomon O, Steinberg DM, Seligshon U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia. 2006;12:490-493. (Pubitemid 44227591)
27. Collins P, Goldman E, Lilley P, Pasi K, Lee C. Clinical experience of factor XI deficiency: the role of fresh frozen plasma and factor XI concentrate. Haemophilia. 1995;1:227-231.
28. Battaglia C, Regnani G, Giulini S, Madgar L, Genazzani A, Volpe A. Severe intraabdominal bleeding after transvaginal oocyte retrieval for IVF-ET and coagulation factor XI deficiency: a case report. J Assist Reprod Genet. 2001;18:178-181. (Pubitemid 32520032)
29. Conde P, Alegria A, Moniz A. Factor IX deficiency. Acta Med Port. 2007;20:375-380.
30. Rabinerson D, Dicker D, Ben-Rafael Z, Dekel A. Hysterectomy in a woman with factor XI deficiency. J Obstet Gynaecol. 2000;20:321-322. (Pubitemid 30333023)
31. Kim S, Srinivas S, Rubin S, Freedman L, Gray H. Delayed hemorrhage after cervical conization unmasking severe factor XI deficiency. Obstet Gynecol. 2004;104:1189-1192.
32. Gué guen P, Galinat H, Blouch M-T, et al. Biological determinants of bleeding in patients with heterozygous factor XI deficiency. Br J Haematol. 2011:156:245-251.
33. Rugeri L, Qué lin F, Chatard B, De Mazancourt P, Negrier C, Dargaud Y. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk. Haemophilia. 2010;16: 771-777.
34. Hellstern P, Muntean W, Schramm W, Seifried E, Solheim BG. Practical guidelines for the clinical use of plasma. Thromb Res. 2002;107, Supplement 1:S53-S57.
35. Martlew V. Peri-operative management of patients with coagulation disorders. Br J Anaesth. 2000;85:446-455.
36. Steinburg M, Saletan S, Funt M, Baker D, Coller B. Manage-ment of factor XI deficiency in gynecologic and obstetric patients. Obstet Gynecol. 1986;68:130-133. (Pubitemid 16090854)
37. Kitchens C. Factor XI: a review of its biochemistry and deficiency. Semin Thromb Hemost. 1991;17:55-72.
38. Purcell G, Nossel H. Factor XI (PTA) deficiency and surgical and obstetrical aspects. Obstet Gynecol. 1970;35:69-74.
39. Kaufmann JE, Vischer UM. Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost. 2003;1:682-689.
40. Franchini M. Prophylactic use of desmopressin in surgery of six patients with symptomatic heterozygous factor XI deficiency. Haematologica. 2000;85:106-107. (Pubitemid 30096905)
41. Bauduer F, Bendriss P, Freyburger G, Ducout L, Marti B. Use of desmopressin for prophylaxis of surgical bleeding in factor XI-deficient patients. Acta Haematologica. 1998;99:52-53. (Pubitemid 28051243)
42. Bond L, Bevan D. Myocardial infarction in a patient with hemophilia treated with DDAVP. N Engl J Med. 1988;318: 121. (Pubitemid 18029309)
43. McLeod B. Myocardial infarction in a blood donor after administration of desmopressin. Lancet. 1990;336:1137-1138. (Pubitemid 20368797)
44. Carless P, Stokes B, Moxey A, Henry D. Desmopressin use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2008;Art No: CD001884.
45. Hoylaerts M, Lijnen H, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta. 1981;673:75-85. (Pubitemid 11149433)
46. Berliner S, Horowitz I, Martinowitz U, Brenner B, Seligsohn U. Dental surgery in patients with severe factor XI deficiency without plasma replacement. Blood Coagul Fibrinolysis. 1992; 3:465-468.
47. Riddell A, Abdul-Kadir R, Pollard D, Tuddenham E, Gomez K. Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery. Thromb Haemost. 2011;106:521-527.
48. Schulman S, Nemeth G. An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency. Haemophilia. 2006;12:223-227.
49. O'Connell NM, Riddell AF, Pascoe G, Perry DJ, Lee CA. Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency. Haemophilia. 2008;14:775-781. (Pubitemid 352016034)
50. Livnat T, Tamarin L, Mor Y, et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies. Thromb Haemost. 2009;102:487-492.
51. Aledort L, Goudemand J, Group HS. United States' factor XI-deficiency patients need a safer treatment. Am J Hematol. 2005;80:301-302. (Pubitemid 41746180)
52. Bolton-Maggs PH, Perry DJ, Chalmers E, et al. The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004;10:593-628. (Pubitemid 39317772)
53. Condie R. A serial study of coagulation factors XII, XI and X in plasma in normal pregnancy and in pregnancy complicated by pre-eclampsia. Br J Obstet Gynaecol. 1976;83:636-639.
54. Nossel H, Lanzkowsky P, Levy S, Mibashan R, Hansen J. A study of coagulation factor levels in women during labour and in their newborn infants. Thromb Diath Haemorrh. 1966;16:185-197.
55. Hilgartner MW, Smith CH. Plasma thromboplastin antecedent (Factor XI) in the neonate. J Pediatr. 1965;66:747-752.
56. Kadir R, Lee C, Sabin C, Pollard D, Economides D. Pregnancy in women with von Willebrand's disease or factor XI deficiency. Br J Obstet Gynaecol. 1998;105:314-321. (Pubitemid 28123582)
57. Salomon O, Seligsohn U. New observations on factor XI deficiency. Haemophia. 2004;10:184-187. (Pubitemid 40045441)
58. Salomon O, Steinberg DM, Tamarin I, Zivelin A, Seligsohn U. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrin. 2005;16:37-41.
59. Baehner RL, Strauss HS. Hemophilia in the first year of life. N Engl J Med. 1966;275:524-528.